title: The coagulopathy in sepsis: significance and implications for treatment.
abstract: Sepsis related coagulopathy ranges from mild laboratory alterations up to severe disseminated intravascular coagulation (DIC). There is evidence that DIC is involved in the pathogenesis of microvascular dysfunction contributing to organ failure. Additionally, the systemic activation of coagulation, by consuming platelets and coagulation factors, may cause bleeding. Thrombin generation via the tissue factor/factor VIIa route, contemporary depression of antithrombin and protein C anticoagulant systems, as well as impaired fibrin degradation, due to high circulating levels of PAI-1, contribute to enhanced intravascular fibrin deposition. This deranged coagulopathy is an independent predictor of clinical outcome in patients with severe sepsis. Innovative supportive strategies aiming at the inhibition of coagulation activation should comprise inhibition of tissue factor-mediated activation or restoration of physiological anticoagulant pathways, as the administration of recombinant human activated protein C or concentrate. In spite of some promising initial studies, additional trials are needed to define their clinical effectiveness in adults and children with severe sepsis.
authors.affiliation: Hematology Unit, Department of Pediatrics, University of Turin;
authors.forename: Paola
authors.initials: P
authors.lastname: Saracco
authors.forename: Pasquale
authors.initials: P
authors.lastname: Vitale
authors.forename: Carlo
authors.initials: C
authors.lastname: Scolfaro
authors.forename: Berardino
authors.initials: B
authors.lastname: Pollio
authors.forename: Mauro
authors.initials: M
authors.lastname: Pagliarino
authors.forename: Fabio
authors.initials: F
authors.lastname: Timeus